Bowhead Specialty (NYSE:BOW) Stock Rating Upgraded by Royal Bank Of Canada

Bowhead Specialty (NYSE:BOWGet Free Report) was upgraded by research analysts at Royal Bank Of Canada to a “moderate buy” rating in a research note issued to investors on Monday,Zacks.com reports.

Other research analysts also recently issued reports about the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Bowhead Specialty in a research note on Tuesday. JMP Securities reduced their target price on shares of Bowhead Specialty from $43.00 to $40.00 and set a “market outperform” rating for the company in a research report on Tuesday, October 14th. Piper Sandler lowered their price target on shares of Bowhead Specialty from $38.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, October 2nd. Zacks Research raised shares of Bowhead Specialty from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Finally, Morgan Stanley decreased their target price on shares of Bowhead Specialty from $31.00 to $29.00 and set an “equal weight” rating on the stock in a research note on Monday, November 17th. Five research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $35.00.

View Our Latest Stock Analysis on BOW

Bowhead Specialty Trading Down 0.7%

BOW stock opened at $27.85 on Monday. Bowhead Specialty has a 12-month low of $23.50 and a 12-month high of $42.29. The stock has a market cap of $912.92 million, a price-to-earnings ratio of 17.85 and a beta of -0.93. The business’s 50-day moving average is $26.21 and its 200 day moving average is $31.23.

Bowhead Specialty (NYSE:BOWGet Free Report) last announced its earnings results on Monday, August 26th. The company reported $0.27 EPS for the quarter. The business had revenue of $65.45 million during the quarter. Bowhead Specialty had a return on equity of 13.53% and a net margin of 10.12%. As a group, equities analysts forecast that Bowhead Specialty will post 1.36 EPS for the current fiscal year.

Hedge Funds Weigh In On Bowhead Specialty

Several institutional investors and hedge funds have recently bought and sold shares of the company. Informed Momentum Co LLC acquired a new position in Bowhead Specialty in the first quarter valued at about $3,137,000. Goldman Sachs Group Inc. raised its stake in shares of Bowhead Specialty by 33.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 121,705 shares of the company’s stock valued at $4,947,000 after acquiring an additional 30,440 shares during the period. Deutsche Bank AG raised its stake in shares of Bowhead Specialty by 131.1% in the 1st quarter. Deutsche Bank AG now owns 15,158 shares of the company’s stock valued at $616,000 after acquiring an additional 8,598 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Bowhead Specialty by 17.5% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,400 shares of the company’s stock worth $301,000 after acquiring an additional 1,100 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Bowhead Specialty by 16.2% during the 1st quarter. Vanguard Group Inc. now owns 752,320 shares of the company’s stock worth $30,582,000 after purchasing an additional 105,138 shares during the period.

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Read More

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.